Impact of D-Amino Acids in Schizophrenia
Biomolecules · 2025
DOI: 10.3390/biom15091270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Serdar M Dursun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry (Neurochemical Research Unit and Bebensee Schizophrenia Research Unit) and Neuroscience and Mental Health Institute, Univers…. Hauptthemen laut MEDLINE: Schizophrenia, Amino Acids, D-Aspartic Acid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 271 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Alberta.
Abstract (Originalsprache)
Most amino acids contain a chiral center and thus, can exist as L- and D-isomers. For many years, it was thought that only the L-isomers were present in mammals. However, in recent decades it has been demonstrated that D-isomers are also present. Three of these amino acids, namely D-serine, D-aspartate, and D-alanine, have been proposed to play a role in the etiology of schizophrenia via interactions with glutamate receptors. D-Serine and D-alanine act at the glycine modulatory site on the NMDA receptor, while D-aspartate acts at the glutamate site on the same receptor. D-aspartate also acts on the mGlu5 receptor and can stimulate glutamate release presynaptically. Preclinical studies have reported that manipulations to reduce brain levels of D-serine, D-aspartate, or D-alanine lead to schizophrenia-relevant behaviors, and clinical studies have reported reduced levels of these D-amino acids in the brain tissue (postmortem) and/or body fluids from schizophrenia patients compared to those noted in controls, although there are some contradictory findings. The possible use of these amino acids and/or the manipulation of their relevant enzymes in the treatment of schizophrenia are described. D-Cysteine has been identified recently in human brain tissue, with the highest values in white matter; demonstration of its involvement in brain development has led to speculation that it could be involved in the etiology of schizophrenia, identifying it as a potential therapy in combination with antipsychotics. Future directions and potential problems that should be considered in studies on D-amino acids and their relevant enzymes in schizophrenia are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry (Neurochemical Research Unit and Bebensee Schizophrenia Research Unit) and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB T6G 2B7, Canada.
ORCID-Profile: Serdar M Dursun, Glen B Baker
Förderung
- University of Alberta
Zitieren
APA
Dursun, S. M., Dursun, L. H., & Baker, G. B. (2025). Impact of D-Amino Acids in Schizophrenia. Biomolecules. https://doi.org/10.3390/biom15091270
Vancouver
Dursun SM, Dursun LH, Baker GB. Impact of D-Amino Acids in Schizophrenia. Biomolecules. 2025. doi:10.3390/biom15091270
BibTeX
@article{Dursun2025,
author = {Dursun, Serdar M and Dursun, Leman H and Baker, Glen B},
title = {Impact of D-Amino Acids in Schizophrenia},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15091270}
}
EUVIMED